Recommendation #2. We recommend investigating the sexual function and ruling out erectile dysfunction in all patients with systemic diseases, especially in those with organ failure (Good clinical practice).
Recommendation #17. All patients treated with anti-androgenic drugs must be informed about possible negative effects on erectile function (Good Clinical Practice).
Recommendation #26. We recommend considering nonorganic and organic risk factors always jointly and in their entirety (Good Clinical Practice).
Recommendation #29. We recommend considering the partner and her/his sexual dysfunctions as direct or indirect risk factors for erectile dysfunction (Good Clinical Practice).
Recommendation #31. We suggest investigating the presence of erectile dysfunction in the workup of couple infertility, particularly when undergoing assisted reproduction techniques (Good Clinical Practice).
Recommendation #32. We recommend against the use of the redundant and stigmatizing term «psychogenic» for patients with non-organic, or idiopathic, erectile dysfunction. (Expert opinion).
Recommendation #33. We recommend against the “exclusion diagnosis”, as it is not evidence-based, of erectile dysfunction. (Good clinical practice).
Recommendation #34. We suggest considering subclinical erectile dysfunction as a taxonomic entity deserving of clinical attention (Expert Opinion).
Recommendation #43. We suggest educational, psychological, psycho-sexological, and marital assessment in all patients with ED (Good clinical practice).
Recommendation #56. We suggest considering psychoanalysis as a therapeutical option in selected patients in whom other therapeutic approaches for erectile dysfunction have failed (Expert opinion).
Recommendation #60. We suggest a combination of chronic and on-demand PDE5i in patients not responding to conventional therapy (Expert Opinion).
Recommendation #61. We recommend against the use of counterfeit PDE5i (Good clinical practice).
Recommendation #62. No sufficient evidence to recommend nutritional supplements is currently available.
